Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 19 hours agoBut longer-term sales are expected to be below 2024 estimates. It will be key to watch how the...
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request
WJXT Jacksonville· 7 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 19 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine maker
CNBC· 2 days agoA vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022....
AstraZeneca withdraws COVID-19 vaccine, citing declining demand
BioPharma Dive via Yahoo Finance· 7 days agoThe move ends a turbulent saga for AstraZeneca, which successfully developed a coronavirus shot but...